{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/fortrea-mdd-advancing-diagnostic-imaging-trials-through-global-experience#webpage",
"url": "https://www.fortrea.com/insights/fortrea-mdd-advancing-diagnostic-imaging-trials-through-global-experience",
"name": "Fortrea MDD: Advancing diagnostic imaging trials through global experience",
"description": "Fortrea Medical Device and Diagnostics (MDD) supports complex diagnostic imaging trials through global operational experience, regulatory expertise, and end-to-end service delivery across the clinical development lifecycle. With experience spanning more than 20 diagnostic imaging studies over the past 10 years, Fortrea supports a broad range of imaging modalities including MRI, PET/CT, SPECT, contrast-enhanced diagnostic imaging, and radiopharmaceutical studies across oncology, neurology, cardiovascular, musculoskeletal, and general diagnostics. The info sheet highlights Fortrea's capabilities in imaging standardization, image quality and endpoint integrity, regulatory compliance, data management and integration, vendor management, cross-regional delivery, patient pathway mapping, and imaging-specific operational planning. Supported by established global site networks, imaging-focused workflows, and experience across early phase through post-marketing studies, Fortrea helps sponsors deliver high-quality, regulatory-compliant diagnostic imaging trials while reducing operational complexity across multi-regional clinical studies."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Fortrea MDD: Advancing diagnostic imaging trials through global experience",
"item": "https://www.fortrea.com/insights/fortrea-mdd-advancing-diagnostic-imaging-trials-through-global-experience"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/fortrea-mdd-advancing-diagnostic-imaging-trials-through-global-experience#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/fortrea-mdd-advancing-diagnostic-imaging-trials-through-global-experience#webpage"
},
"headline": "Fortrea MDD: Advancing diagnostic imaging trials through global experience",
"description": "Fortrea Medical Device and Diagnostics (MDD) supports complex diagnostic imaging trials through global operational experience, regulatory expertise, and end-to-end service delivery across the clinical development lifecycle. With experience spanning more than 20 diagnostic imaging studies over the past 10 years, Fortrea supports a broad range of imaging modalities including MRI, PET/CT, SPECT, contrast-enhanced diagnostic imaging, and radiopharmaceutical studies across oncology, neurology, cardiovascular, musculoskeletal, and general diagnostics. The info sheet highlights Fortrea's capabilities in imaging standardization, image quality and endpoint integrity, regulatory compliance, data management and integration, vendor management, cross-regional delivery, patient pathway mapping, and imaging-specific operational planning. Supported by established global site networks, imaging-focused workflows, and experience across early phase through post-marketing studies, Fortrea helps sponsors deliver high-quality, regulatory-compliant diagnostic imaging trials while reducing operational complexity across multi-regional clinical studies.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2026-07/tdna-regulations-in-precision-oncology_0.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-07-14",
"dateModified": "2026-07-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-07/fortrea-mdd-diagnostic-imaging-trials.pdf",
"encodingFormat": "application/pdf"
}
}
]
}